In the documentary short, “1001 cuts,” Sarah Temkin, a gynecologic oncologist, examines the enduring misogyny of medicine, particularly in the operating room.
Women make up more than half of the U.S. population and are well represented in medicine—but not so much in the top jobs in oncology.
In 2018, Narjust Florez was attending a panel at the annual meeting of the American Society of Clinical Oncology, and on the stage were three physicians—one woman and two men.
OK, name a movie doctor—fast!Chances are, you are thinking of Robin Williams as Patch Adams in the eponymous flick or of Harrison Ford as Dr. Richard Kimble in “The Fugitive.”
Last year, the NIH announced that at the direction of Congress, the organization would tighten rules for reporting sexual and workplace harassment by investigators funded by the NIH.
After taking eight months to respond to a House committee’s questions about policies on handling of sexual misconduct cases, a letter from NIH has provided answers that critics describe as vague and inadequate.
Last month, the NIH finally responded to a request by the House Committee on Energy and Commerce to obtain information about NIH’s handling of sexual harassment complaints.
Undeterred by NIH’s failure to address a set of questions submitted seven months ago, a House oversight committee is persisting with its investigation into handling of sexual harassment complaints at institutions that receive federal funding.
A study published in Blood Advances found that women make up 37.7% of all speakers at hematology and medical oncology board review lectures.
NIH is now required by law to direct grantee institutions to report senior personnel who are disciplined for misconduct, sexual or otherwise.
